Research Article

Relationship of Serum IL-12 to Inflammation, Hematoma Volume, and Prognosis in Patients With Intracerebral Hemorrhage

Table 3

Factors associated with early neurological deterioration in patients with ICH.

VariablesEarly neurological deterioration value
Yes (n = 66)No (n = 143)

Gender (male/female)40/2681/620.590
Age (years)70.2 ± 15.465.1 ± 21.30.0035
Admission time (hours)6.2 (9.5)5.6 (8.9)0.426
Blood collection time (hours)7.2 (7.1)6.8 (7.3)0.194
Initial SBP (mmHg)162.3 ± 23.5159.4 ± 26.80.438
Initial DBP (mmHg)93.8 ± 19.690.4 ± 23.20.208
Hypertension (n (%))47 (71.2)88 (61.5)0.174
Current smoking (n (%))22 (33.3)45 (31.5)0.788
Atrial fibrillation (n (%))18 (27.3)28 (19.6)0.212
Lobar hemorrhage (n (%))18 (27.3)27 (18.9)0.170
Infratentorial hemorrhage (n (%))12 (18.2)25 (17.5)0.902
Intraventricular hemorrhage (n (%))17 (25.8)32 (22.4)0.592
Admission NIHSS16.0 (9.0)8.0 (8.0)<0.001
Hematoma volume (mL)21.6 (12.3)16.5 (14.3)0.005
WBC (×109/L)10.8 ± 2.59.0 ± 2.60.032
Serum glucose (mmol/L)8.2 ± 1.57.0 ± 1.10.019
Serum CRP (mg/L)26.7 (5.68)19.7 (9.8)<0.001
Serum TNF-α (pg/mL)70.0 (14.8)56.2 (21.4)<0.001
Serum IL-12 (pg/mL)82.9 (14.9)65.8 (26.3)<0.001